Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.

Michele LamuragliaGuillaume BarroisDelphine Le Guillou-BuffelloMathieu SantinAnne KerbolEva ComperatAlain CoronOlivier LucidarmeS Lori Bridal

Published in: Technology in cancer research & treatment (2020)

Dynamic contrast-enhanced ultrasound, therefore, presents strong potential to monitor microvascular modifications during antiangiogenic therapy, a key role to monitoring antiangiogenic combining therapy to adapt dose range drug.

Keyphrases

contrast enhanced ultrasound
endothelial cells
emergency department
stem cells
mesenchymal stem cells
bone marrow
climate change
drug induced
replacement therapy
chemotherapy induced